Showing results (2391-2400 of 2,546) with videos related to

Sort By:
Pageof 255
Cancer Research|September 4, 2016
Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell CancersDamian J Green, Shani L Frayo, Yukang Lin, et al.
Blood|August 24, 2011
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasmsAngela G Fleischman, Karl J Aichberger, Samuel B Luty, et al.
Molecular Psychiatry|August 22, 2025
Predictive value of subgenual cingulate normative connectivity to TMS treatment site for antidepressant response in routine clinical practice: a prospective, multisite cohort studySanaz Khosravani, Stephan T Palm, William Drew, et al.
The Lancet. Oncology|May 1, 2015
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 studyMaria Corinna A Palanca-Wessels, Myron Czuczman, Gilles Salles, et al.
Contemporary Clinical Trials|April 4, 2017
Design of a pragmatic trial in minority children presenting to the emergency department with uncontrolled asthma: The CHICAGO PlanJerry A Krishnan, Molly A Martin, Cortland Lohff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 4, 2006
HER2 testing in breast cancer: NCCN Task Force report and recommendationsRobert W Carlson, Susan J Moench, M Elizabeth H Hammond, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 22, 2009
An admixture scan in 1,484 African American women with breast cancerLaura Fejerman, Christopher A Haiman, David Reich, et al.
Frontiers in Drug Delivery|September 29, 2023
Lyophilization Process Engineering and Thermostability of ID93 + GLA-SE, a Single-Vial Adjuvanted Subunit Tuberculosis Vaccine Candidate for Use in Clinical StudiesTimothy S Dutill, Michelle C Archer, Joseph McCollum, et al.
Blood|October 26, 2000
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasO W Press, J F Eary, T Gooley, et al.
Breast Cancer Research and Treatment|January 12, 2008
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analysesDavid Cameron, Michelle Casey, Michael Press, et al.
Pageof 255